Background: Warts, or verrucae, are mucosal human papilloma virus (HPV) infections that are very challenging to treat.

Objective: To compare the safety and efficacy of intralesional injection of vitamin D3 versus intralesional injection of candida albicans antigen for plantar warts.

Methods: Forty patients were included in the study and were divided into two groups (A&B) with 20 patients each. Group A received intralesional vitamin D3 while Group B received intralesional Candida antigen. Injection was done every 3 weeks until clearance of warts or a maximum of three treatments.

Results: Nine patients showed complete clearance in group A (45%), while 6 patients (30%) showed partial response and no response in 5 patients (25%) of group (A). As for group (B), complete clearance of the treated warts was observed in 8 patients (40%), partial response in 6 patients (30%) while no response was observed in 6 patients (30%). No superiority of one treatment to the other was observed nor was any statistical significance in both groups’ responses noted.

Conclusion: Treatment of multiple warts by intralesional injection of candida antigen or vitamin D3 is safe and effective, with good cure rates, has an excellent safety profile, with minimal recurrences and statistically equivalent. J Drugs Dermatol. 2021;20(5):546-549. doi:10.36849/JDD.5264.

Download full-text PDF

Source
http://dx.doi.org/10.36849/JDD.5264DOI Listing

Publication Analysis

Top Keywords

injection candida
12
intralesional injection
12
patients 30%
12
intralesional vitamin
8
candida albicans
8
albicans antigen
8
patients
8
group received
8
received intralesional
8
candida antigen
8

Similar Publications

Background And Aims Of The Study: Fluctuations in environmental temperature and humidity significantly affect human physiology and disease manifestation. In the Lingnan region of China, high summer temperatures and humidity often cause symptoms like diminished appetite, sticky tongue coating, sticky stool, unsatisfactory defecation, lethargy, and joint heaviness. These are referred to as "Dampness Syndrome" in Traditional Chinese Medicine (TCM).

View Article and Find Full Text PDF

Background: Candida albicans is the primary cause of vulvovaginal candidiasis, a worldwide health concern for women. The use of supplemental methods, such as antimicrobial photodynamic therapy (aPDT) and probiotics, was promoted by the ineffectiveness of the existing antifungal drugs.

Methods: This study examines the combined effects of probiotics (Bacillus and Enterococcus isolated from the fermented pickles) and PDT (using red laser (655 nm, 18 J/cm) as a light source and methylene blue dye (30 mg/mL) as a photosensitizer) on the in vitro virulence activity of C.

View Article and Find Full Text PDF

Sertraline exhibits in vivo antifungal activity against Candida auris and enhances the effect of voriconazole in combination.

Microb Pathog

December 2024

Universidad Autónoma de Nuevo León, Facultad de Medicina, Departamento de MicrobiologíaAve. Francisco I. Madero & Dr. Eduardo A. Pequeño, S/n. Colonia Mitras Centro, 64460, Monterrey, N.L, Mexico. Electronic address:

Article Synopsis
  • * Researchers tested sertraline, a common antidepressant, for its antifungal properties and found it reduced fungal levels in mice infected with C. auris, particularly in the kidneys.
  • * The combination of sertraline and voriconazole showed a stronger antifungal effect than either drug alone, suggesting a potential new treatment approach for C. auris infections.
View Article and Find Full Text PDF

Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against biofilm.

Front Microbiol

November 2024

School of Basic Medical Sciences, Key Laboratory of Microbio and Infectious Disease Prevention & Control, Guizhou Medical University, Guiyang, China.

Article Synopsis
  • Candidiasis is a serious fungal infection that can become life-threatening, and drug-resistant strains are on the rise, highlighting the need for new treatments.
  • AMP-17, an antimicrobial peptide, has shown promising antifungal effects and can enhance the effectiveness of fluconazole, a common antifungal drug, in treating systemic candidiasis.
  • In tests on infected larvae and mice, AMP-17 significantly improved survival rates, reduced fungal loads, and minimized inflammation, suggesting it could be a novel treatment option for candidiasis, especially when used alongside fluconazole.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!